These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29099692)

  • 1. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
    Aoyama-Maeda N; Horino T; Ichii O; Terada Y
    Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
    Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
    J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
    Tulbă D; Balea M; Băicuş C
    Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
    Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
    Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
    Lin CI; Yu HH; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
    Clin Rheumatol; 2012 Aug; 31(8):1223-30. PubMed ID: 22615046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
    Jiang N; Li MT; Wu D; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrophage activation syndrome in a newborn infant born to a mother with autoimmune disease.
    Park JH; Kim SH; Kim HJ; Lee SJ; Jeong DC; Kim SY
    J Perinatol; 2015 Feb; 35(2):158-60. PubMed ID: 25627282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.
    Shah K; Porter A; Takhar G; Reddy V
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32269047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.
    Junga Z; Stitt R; Tracy C; Keith M
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28827301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
    Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
    Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
    Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
    Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
    Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.
    Dall'Ara F; Cavazzana I; Frassi M; Taraborelli M; Fredi M; Franceschini F; Andreoli L; Rossi M; Cattaneo C; Tincani A; Airò P
    Reumatismo; 2018 Jul; 70(2):100-105. PubMed ID: 29976044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful therapy of macrophage activation syndrome with dexamethasone palmitate.
    Nakagishi Y; Shimizu M; Kasai K; Miyoshi M; Yachie A
    Mod Rheumatol; 2016 Jul; 26(4):617-20. PubMed ID: 24754272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effective treatment of a refractory case of systemic lupus erythematosus with low-dose tacrolimus].
    Oki E; Tsugawa K; Suzuki K; Tanaka H
    Nihon Jinzo Gakkai Shi; 2007; 49(8):1020-4. PubMed ID: 18186231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus.
    Kikuchi H; Yamamoto T; Asako K; Takayama M; Shirasaki R; Ono Y
    Mod Rheumatol; 2012 Apr; 22(2):308-11. PubMed ID: 21773824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRECORDIAL PAIN, LEUKOCYTOSIS AND BICYTOPENIA IN A TEENAGER WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS UNDER IMMUNOSUPPRESSIVE THERAPY.
    Vieira MS; Andrade FR; Brandão LMKR; Nóbrega VTD; Guissa VR; Provenza JR
    Rev Paul Pediatr; 2019; 37(2):252-256. PubMed ID: 30810692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage.
    Sukhadiya P; Kumar P; Meena DS; Kumar P H A; Vijayan N; Garg P; Garg MK
    Reumatismo; 2023 Mar; 74(4):. PubMed ID: 36942984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
    Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B
    Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.